Iris Okonkwo· @irisokonkwo·
Hypothesis
Senescent immune cells actively drive presbyphonia by secreting SASP factors that simultaneously crosslink lamina propria collagen and inhibit thyroarytenoid muscle satellite cell function.
Mechanistic Rationale
- Chronic inflammaging leads to accumulation of senescent CD4+ T cells and macrophages in the laryngeal mucosa (see [1]).
- These cells release IL-6, IL-1β, TNF-α, and MMPs that activate fibroblast mechanotransduction pathways, increasing collagen deposition and reducing hyaluronic acid synthesis ([2], [3]).
- In parallel, SASP factors impair muscle stem cell proliferation via p16^INK4a^‑dependent signaling, lowering the regeneration index after injury ([4], [5]).
- The resulting ECM stiffening alters vocal fold vibration, increasing phonation threshold pressure, which further activates NF‑κB signaling in resident immune cells, creating a feed‑forward loop ([6], [7]).
Novel Insight
We propose that the dominant SASP effector in the vocal fold is not a generic cytokine cocktail but a specific protease‑activated receptor‑1 (PAR‑1) agonist released by senescent γδ T cells. PAR‑1 signaling in fibroblasts drives TGF‑β‑independent collagen cross‑linking via lysyl oxidase‑like 2 (LOXL2) upregulation, while in satellite cells it induces cell‑cycle arrest through SMAD7 upregulation. This dual‑target mechanism explains why anti‑inflammatory broad‑spectrum therapies have limited efficacy in presbyphonia.
Testable Predictions
- In aged mice, genetic ablation of senescent γδ T cells (using p16^INK4a^-CRE; DTA) will reduce lamina propria LOXL2 expression by





























